journal cover

Efficacy and Tolerance of Synthetic Cannabidiol for Treatment of Drug Resistant Epilepsy

Frontiers in Neurology

Jan 11, 2020

Kerstin A KlotzJulia Jacobs

Abstract

Objective: Controlled and open label trials have demonstrated efficacy of cannabidiol for certain epileptic encephalopathies. However, plant derived cannabidiol products have been used almost exclusively. Efficacy of synthetically derived cannabidiol has not been studied before. The obj...read more

Mentioned in this Paper

Study
Seizures
Titration Method
Cannabidiol
Open Label Study
Encephalopathic Epilepsy
Diarrhea
Convulsive Seizures
Anticonvulsant Therapy
Adverse Event
13
1
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Similar Papers Found In These Feeds

Epilepsy

Epilepsy is a chronic neurological disorder characterized by unprovoked and recurrent seizures. Discover the latest research on factors and mechanisms that underlie epilepsy here.

Drug Resistant Epilepsy

Drug-resistant epilepsy, also known as refractory or pharmacoresistant epilepsy, is defined as failure of adequate trials of two appropriate and tolerated antiepileptic drugs (as monotherapies or in combination) to achieve sustained seizure freedom. Discover the latest research on drug-resistant epilepsy here.

Neural Networks

Here is the latest research on physiological and in silico networks and circuits implicated in the nervous system.

© 2020 Meta ULC. All rights reserved

Efficacy and Tolerance of Synthetic Cannabidiol for Treatment of Drug Resistant Epilepsy

Frontiers in Neurology

Jan 11, 2020

Kerstin A KlotzJulia Jacobs

PMID: 31920934

DOI: 10.3389/fneur.2019.01313

Abstract

Objective: Controlled and open label trials have demonstrated efficacy of cannabidiol for certain epileptic encephalopathies. However, plant derived cannabidiol products have been used almost exclusively. Efficacy of synthetically derived cannabidiol has not been studied before. The obj...read more

Mentioned in this Paper

Study
Seizures
Titration Method
Cannabidiol
Open Label Study
Encephalopathic Epilepsy
Diarrhea
Convulsive Seizures
Anticonvulsant Therapy
Adverse Event
13
1

Similar Papers Found In These Feeds

Epilepsy

Epilepsy is a chronic neurological disorder characterized by unprovoked and recurrent seizures. Discover the latest research on factors and mechanisms that underlie epilepsy here.

Drug Resistant Epilepsy

Drug-resistant epilepsy, also known as refractory or pharmacoresistant epilepsy, is defined as failure of adequate trials of two appropriate and tolerated antiepileptic drugs (as monotherapies or in combination) to achieve sustained seizure freedom. Discover the latest research on drug-resistant epilepsy here.

Related Papers

Lancet Neurology

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

Lancet NeurologyJanuary 3, 2016
Orrin DevinskyMaria Roberta Cilio
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.
/papers/efficacy-and-tolerance-of-synthetic-cannabidiol/31920934